Regard Lipidomics in human nonalcoholic fatty liver disease

References

• Bass NM. Lipidomic dissection of nonalcoholic steatohepatitis: moving beyond foie gras to fat traffic. Hepatology 51, 4–7 (2010).
   Google Scholar
• Puri P, Baillie RA, Wiest MM et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 46, 1081–1090 (2007).
   Google Scholar
• Buechler C, Wanninger J, Neumeier M. Adiponectin, a key adipokine in obesity related liver diseases. World J. Gastroenterol. 17, 2801–2811 (2011).
   Google Scholar
• Chavez JA, Summers SA. A ceramide-centric view of insulin resistance. Cell Metab. 15, 585–594 (2012).
   Google Scholar
• Lamaziere Antonin WC, Quinn Peter J. Perturbations of lipid metabolism indexed by lipidomic biomarkers. Metabolites 2, 1–18 (2012).
   Google Scholar
• Araya J, Rodrigo R, Videla LA et al. Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin. Sci. (Lond.) 106, 635–643 (2004).
   Google Scholar
• Barr J, Caballeria J, Martinez-Arranz I et al. Obesitydependent metabolic signatures associated with nonalcoholic fatty liver disease progression. J. Proteome Res. 11, 2521–2532 (2012).
   Google Scholar
• Barr J, Vazquez-Chantada M, Alonso C et al. Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease. J. Proteome Res. 9, 4501–4512 (2010).
   Google Scholar
• Eisinger K, Liebisch G, Schmitz G et al. Lipidomic analysis of serum from high fat diet induced obese mice. Int. J. Mol. Sci. 15, 2991–3002 (2014).
   Google Scholar
• Puri P, Wiest MM, Cheung O et al. The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 50, 1827–1838 (2009).
   Google Scholar
• Feldstein AE, Lopez R, Tamimi TA et al. Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J. Lipid Res. 51, 3046–3054 (2010).
   Google Scholar
• Allard JP, Aghdassi E, Mohammed S et al. Nutritional assessment and hepatic fatty acid composition in nonalcoholic fatty liver disease (NAFLD): a cross-sectional study. J. Hepatol. 48, 300–307 (2008).
   Google Scholar
• Min HK, Kapoor A, Fuchs M et al. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab. 15, 665–674 (2012).
   Google Scholar
• Ioannou GN, Haigh WG, Thorning D, Savard C. Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis. J. Lipid Res. 54, 1326–1334 (2013).
   Google Scholar
• Wattacheril J, Seeley EH, Angel P et al. Differential intrahepatic phospholipid zonation in simple steatosis and nonalcoholic steatohepatitis. PLoS ONE 8, e57165 (2013).
   Google Scholar
• Vance DE. Role of phosphatidylcholine biosynthesis in the regulation of lipoprotein homeostasis. Curr. Opin. Lipidol. 19, 229–234 (2008).
   Google Scholar
• Oude Elferink RP, Beuers U. Targeting the ABCB4 gene to control cholesterol homeostasis. Expert Opin. Ther. Targets 15, 1173–1182 (2011).
   Google Scholar
• Aranha MM, Cortez-Pinto H, Costa A et al. Bile acid levels are increased in the liver of patients with steatohepatitis. Eur. J. Gastroenterol. Hepatol. 20, 519–525 (2008).
   Google Scholar
• Lehmann R, Franken H, Dammeier S et al. Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver. Diabetes Care 36, 2331–2338 (2013).
   Google Scholar
• Promrat K, Longato L, Wands JR, de la Monte SM. Weight loss amelioration of non-alcoholic steatohepatitis linked to shifts in hepatic ceramide expression and serum ceramide levels. Hepatol. Res. 41, 754–762 (2011).
   Google Scholar
• Wallner S, Schmitz G. Plasmalogens the neglected regulatory and scavenging lipid species. Chem. Phys. Lipids 164, 573–589 (2011).
   Google Scholar
• Zein CO, Lopez R, Fu X et al. Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism. Hepatology 56, 1291–1299 (2012).
   Google Scholar